CRIS Current Research Information System

MANFRINI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.119
NA - Nord America 2.047
EU - Europa 1.453
AF - Africa 153
Continente sconosciuto - Info sul continente non disponibili 123
SA - Sud America 82
OC - Oceania 2
Totale 5.979
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.007
VN - Vietnam 926
SG - Singapore 429
GB - Regno Unito 397
CN - Cina 384
IT - Italia 238
SE - Svezia 195
DE - Germania 184
HK - Hong Kong 103
FR - Francia 96
IN - India 76
NL - Olanda 67
BR - Brasile 62
RU - Federazione Russa 61
IE - Irlanda 55
TG - Togo 54
BD - Bangladesh 45
JP - Giappone 40
ZA - Sudafrica 33
NG - Nigeria 32
EE - Estonia 28
FI - Finlandia 26
UA - Ucraina 25
CA - Canada 24
CI - Costa d'Avorio 22
JO - Giordania 20
BE - Belgio 18
BG - Bulgaria 17
KR - Corea 11
IQ - Iraq 10
IR - Iran 10
PH - Filippine 10
PL - Polonia 9
TH - Thailandia 9
CH - Svizzera 8
AR - Argentina 7
ID - Indonesia 7
ES - Italia 6
TW - Taiwan 6
MX - Messico 5
PK - Pakistan 5
SA - Arabia Saudita 5
SC - Seychelles 5
AT - Austria 4
CL - Cile 4
EC - Ecuador 4
EU - Europa 4
JM - Giamaica 4
TR - Turchia 4
GR - Grecia 3
LB - Libano 3
MK - Macedonia 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
PY - Paraguay 2
QA - Qatar 2
RS - Serbia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
VE - Venezuela 2
AU - Australia 1
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
TM - Turkmenistan 1
Totale 5.860
Salva come PNG Salva come JPEG
Città #
Dong Ket 449
Southend 353
Singapore 315
Ashburn 225
Chandler 216
Fairfield 136
Ann Arbor 103
Hong Kong 100
San Jose 93
Beijing 88
Ho Chi Minh City 83
Houston 83
Seattle 74
Wilmington 69
Woodbridge 69
Hanoi 67
Cambridge 61
Santa Clara 60
Princeton 56
Dublin 54
Lomé 54
Boardman 50
New York 38
Tokyo 37
Los Angeles 35
Bologna 30
Nanjing 30
Westminster 28
Padova 27
Munich 26
Medford 24
Lauterbourg 23
Abidjan 22
Abeokuta 20
Amman 19
Milan 19
Berlin 18
Brussels 18
Helsinki 18
Bremen 17
Council Bluffs 17
Haiphong 17
Sofia 17
Redwood City 16
Da Nang 15
Saint Petersburg 14
Hebei 13
Redondo Beach 13
São Paulo 13
Turin 13
Frankfurt am Main 12
Jinan 12
Buffalo 11
Shenyang 11
Toronto 11
Florence 10
London 10
Nanchang 10
Redmond 10
San Diego 10
Changsha 9
Jiaxing 9
Shanghai 9
Dallas 8
Paris 8
Rome 8
Chennai 7
Turku 7
Bern 6
Chengdu 6
Chicago 6
Haikou 6
Hải Dương 6
Orem 6
Phoenix 6
San Francisco 6
Warsaw 6
Amsterdam 5
Brooklyn 5
Düsseldorf 5
Guangzhou 5
Hangzhou 5
Kingston 5
Ningbo 5
Norwalk 5
Taizhou 5
Zhengzhou 5
Bangkok 4
Bareggio 4
Bühl 4
City of London 4
Cosenza 4
Dearborn 4
Falkenstein 4
Falls Church 4
Hyderabad 4
Johannesburg 4
Monmouth Junction 4
Montreal 4
Naples 4
Totale 3.783
Salva come PNG Salva come JPEG
Nome #
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization 326
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 314
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 303
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 289
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 278
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 252
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 250
Fanconi anemia gene variants in therapy-related myeloid neoplasms 250
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 240
Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data 238
Chromothripsis in AML patients: A new mechanism of cancer initiation and progression 235
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 231
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 216
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 214
Impact on survival of catastrophic karyotype events in 101 consecutive acute myeloid leukemia (AML) patients: High risk karyotype and chromothripsis 194
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 190
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 186
An analysis pipeline for variant discovery in Whole Exome Sequencing data of cancer samples. 179
The Genomic and Transcriptomic Landscape of Systemic Mastocytosis 176
Survival and outcome data observed in 98 patients affected by acute myeloid leukemia undergoing chemotherapy consolidation courses treatment followed by autologous bone marrow transplantation (auto-BMT) 174
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 174
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 166
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 159
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 158
Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia 155
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 154
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 153
New JAK2 heterozygous loss: A role in overall survival in acute myeloid leukemia patients 125
Totale 5.979
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.333
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022560 0 18 33 59 60 31 17 28 31 39 131 113
2022/2023828 109 129 48 114 65 53 27 36 135 22 65 25
2023/2024204 3 34 10 26 6 54 13 16 14 11 7 10
2024/2025671 9 114 66 53 63 14 85 34 6 75 31 121
2025/20261.603 159 61 105 94 196 75 125 37 448 154 83 66
2026/202772 42 30 0 0 0 0 0 0 0 0 0 0
Totale 5.979